Matthew Helfrich, Chief Investment Strategist at Waldron Wealth Management, tells Wall Street Week why he’s focused on cyclically adjusted P/E ratios:
Previous post: FDA, Big Pharma Boosting Small And Mid-Cap Biotech
Next post: Old Names – New Values?